Skip to main content
search

Strategic Leadership

Sign up

Latest resources

Featured resource

Upcoming strategic leadership webinars

Popular resources

Meet our experts at the following events

Conference

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois
Conference

ACoP 2025

October 18 - 21, 2025
Conference

American College of Toxicology 2025 Annual Meeting

November 16 - 19, 2025 – Phoenix, Arizona – Booth 717

All Strategic Leadership resources

Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Webinar

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Certara Products, Certara Services, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Blog

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Webinar

Three Approaches to AI Adoption in Regulatory Writing

Certara Products, On-Demand Webinar

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

Certara Products - Phoenix, Certara Products - Pinnacle 21, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Blog

The end of animal testing? Transitioning to models is promising — but no silver bullet

Certara Products - Simcyp, Homepage Latest, Modeling and Simulation, Press Coverage

Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation

Certara Products, Certara.AI, Drug Development, Webinar

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Blog

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, On-Demand Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, On-Demand Webinar

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

Cardiovascular, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.